Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia
- PMID: 27099499
- PMCID: PMC4820214
- DOI: 10.2147/NDT.S103687
Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia
Abstract
Here, we report a female patient developing neuroleptic malignant syndrome following the use of a combination of clozapine and haloperidol. Subsequently, the patient presented withdrawal effects after an abrupt discontinuation of clozapine. Psychiatrists not aware of possible clozapine-withdrawal effects may misdiagnose as a part of the primary mental illness or as the initial symptoms worsening, if unrecognized.
Keywords: clozapine; neuroleptic malignant syndrome; schizophrenia; withdrawal effect.
References
-
- Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry. 2004;65:464–470. - PubMed
-
- Gambassi G, Capurso S, Tarsitani P, Liperoti R, Bernabei R. Fatal neuroleptic malignant syndrome in a previously long-term user of clozapine following its reintroduction in combination with paroxetine. Aging Clin Exp Res. 2006;18:266–270. - PubMed
-
- Stanilla JK, de Leon J, Simpson GM. Clozapine withdrawal resulted in delirium with psychosis: a report of three cases. J Clin Psychiatry. 1997;58:252–255. - PubMed
-
- Lee JW, Robertson S. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report. Ann Clin Psychiatry. 1997;9:165–169. - PubMed
-
- Strawn JR, Keck PE, Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164:870–876. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
